Results 91 to 100 of about 7,224 (167)

Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials. [PDF]

Open Forum Infect Dis
Post FA, Wohl D, Liegeon G, Brar I, Hagins D, Yazdanpanah Y, Avihingsanon A, Liu H, Aizen K, Hindman JT, Gupta S.   +10 more
europepmc   +1 more source

Tenofovir alafenamide: safer, but questions remain

The Lancet HIV, 2016
Boyd, MA, Cooper, DA
openaire   +3 more sources

Efficacy and tolerability of tenofovir alafenamide fumarate prophylaxis in HBV-infected individuals receiving chemo/immunosuppressive therapy. [PDF]

Hepatol Forum
Dilber F, Durak S, Unsal Y, Demir M, Yildirim AE, Ellik ZM, Mehdiyev S, Adanir H, Yapali S, Demirtas CO, Ucbilek E, Balaban Y, Ekmen N, Gokcan H, Koc ES, Dincer D, Sezgin O, Simsek H, Tozun N, Arslan M, Idilman R, Etik DO, Gokcen P, Ari D, Ozdil K, Akdogan M, Boyacioglu S.   +26 more
europepmc   +1 more source

Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China. [PDF]

J Clin Transl Hepatol
Hou J, Ning Q, Duan Z, Chen Y, Xie Q, Zhang L, Wu S, Tang H, Li J, Lin F, Yang Y, Gong G, Luo Y, Chen Y, Abramov F, Yee LJ, Wang H, Mateo R, Yazdi T, Botros I, Chen C, Huang Y, Zhang M, Jia J.   +23 more
europepmc   +1 more source

Efficacy and Safety of Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate for Preventing Mother-to-Child Transmission of Hepatitis B in Treatment-Naïve mothers: An Observational Study. [PDF]

Virol J
Yang X, Chen J, Duan L, Li X, Cheng W, Chen Y, Huang Y, Huang Z.   +7 more
europepmc   +1 more source

Evaluation of the Efficacy of Tenofovir Alafenamide in Patients with Low-Level Viremia Under Chronic Hepatitis B Treatment. [PDF]

Viruses
Tahmaz A, Yıldız Dikmen M, Yıldırım F, Öztürk Kaygusuz T, Karabay O, Çelen MK, Alkan S, Damar Çakırca T, Akgül F, Akhan S, Gürbüz E, Özer Balin Ş, Çelik M, Çabalak M.   +13 more
europepmc   +1 more source

Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV in Asia: 24-Month findings from the observational BICSTaR study. [PDF]

Medicine (Baltimore)
Yang CJ, Kim YS, Choi JY, Choy CY, Lu PL, Tsai HC, Ryu J, Harrison R, Chang J, Mo B, Lee SH, Hung CC.   +11 more
europepmc   +1 more source

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV: A Real-World Data from the Spanish BICSTaR Cohort. [PDF]

HIV AIDS (Auckl)
Inciarte A, Miralles C, Silva-Klug A, Revollo B, García Deltoro M, Portilla J, Antela A, Castaño Carracedo MÁ, De Álvaro C, Ramroth J, González-Cordón A, Mallolas J.   +11 more
europepmc   +1 more source

Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection-General and Special Populations. [PDF]

Aliment Pharmacol Ther
Mak LY, Hu TH, Yap DYH.
europepmc   +1 more source

Immune recovery following switch from EFV-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed immunological non-responders: a 144-week real-world cohort study in China. [PDF]

Front Immunol
Yang H, Yu Q, Li M, Liu M.
europepmc   +1 more source